Category: Finance
Race Oncology releases ‘striking’ interim Phase 2 AML trial results
Bisantrene shows promise as treatment in relapsed or refractory acute myeloid leukaemia patients who have run out of options In combination with fludarabine and [more…]
10 at 11ish: Which junior just got a licence to explore next to De Grey’s Hemi gold discovery?
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live [more…]
Market Highlights: How the RBA call today would impact mortgages, and 5 ASX small caps to watch
ASX to fall modestly on Tuesday after a lacklustre session in New York RBA expected to hand down a 25bp rate increase today Mozo explains [more…]
Long Shortz with Corella Resources: The best of both worlds at Tampu
Stockhead’s Ashtyn Hiron sits down with Corella Resources (ASX:CR9) CEO Jess Maddren to get the short end of the long story on the company’s Tampu high priority [more…]
ADX Energy eyes thicker target areas at Anshof-2 to significantly increase 2P reserves and oil production
Anshof-2 spudding planned for 11 November with commencement of rig-up ADX drilling targeting thicker mapped sands could result in a significant 300bpd increase to proven [more…]
Bubalus Resources locks in highly prospective Yinnietharra lithium tenements
Bubalus Resources completes acquisition of the Yinnietharra lithium tenements in the Gascoyne region Project in same “Goldilocks Zone” near the Thirty Three Supersuite granite contact [more…]
No, this is a ‘recession play’: Berkshire’s Q3 earnings jump more than 40pc
Warren Buffett’s business buffet, the conglomerate that is Berkshire Hathaway, dropped its Q3 report over the weekend. And somehow, despite reporting a net loss of [more…]
MoneyTalks: Silk Logistics to rise on stable revenue; Shine Justice at ‘inflection point’
MA Moelis has initiated coverage on two ASX stocks Silk Logistics is slapped a Buy rating on its stable revenue base Shine Justice also gets [more…]
Closing Bell: Smart and casual, ASX makes it five in a row; next up – rates and horse races
ASX200 closes +0.28% higher Healthcare leads gains, ASX All Gold rises over +3% Small caps led by takeover target Whispir The Australian sharemarket has [more…]
ASX Large Caps: CSL, Resmed, and Westpac led gainers; data shows Aussie economy is softening
ASX climbed on Monday, tracking US stocks CSL, Resmed, and Westpac were the main gainers RBA expected to hike 25bp tomorrow The ASX inched [more…]